Recently, the National Sci-Tech Conference, the National Science and Technology Award Conference, and the general assemblies of the members of the Chinese Academy of Sciences and the Chinese Academy of Engineering were grandly held in Beijing. The event honored recipients of the 2023...

Recently, JumpCan Pharmaceutical received the Drug Registration Certificates (Certificate No. 2024S01128 and 2024S01129) issued by the National Medical Products Administration (NMPA) for Fexofenadine Hydrochloride for Suspension in two strengths: 30mg and 15mg. This makes JumpCan...

Recently, the JD Pharmacy 8th Anniversary Partner Conference was grandly held, during which the JD Health "Social Responsibility Award" was presented to recognize brand enterprises that have made significant contributions to society. JumpCan Pharmaceutical was honored with the...

On April 15, HR Value Net released its "Top Series" employer brand list. JumpCan Pharmaceutical was awarded the title of "2024 Top Graduate Employer Brands" for its outstanding performance in collaborative university research and the employer brand index system.

On April 8, the 2024 Wuzhen Health Conference was successfully held. JumpCan Pharmaceutical's exclusive product, Xiao'er Chiqiao Qingre Granules (Tonpei), stood out among numerous star products and wins "Most Popular Star Product in Pharmacies" award again. This award stems from...

On January 29, the “2024 Top 100 Most Influential Employer Brands in China” list was officially announced, with JumpCan Pharmaceutical securing the 17th position. This award, organized by HR Value Net with China Human Resource Brand Academy as the research body, has become a key...

Arriving as scheduled, surging with energy
On January 26, JumpCan Pharmaceutical’s 10th Anniversary of Listing Celebration& 2024 Annual Conference was successfully held...

Recently, the Fifth Meeting of the Sixth Council of the Jiangsu Quality Association for Pharmaceuticals was successfully held in Nanjing. During the meeting, the selection results for the "Outstanding Quality Management Enterprise in Jiangsu Pharmaceutical Industry" and "Outstanding Quality...

Recently, to further foster a market environment built on honesty and trustworthiness, enhance corporate social responsibility, and advance the development of the enterprise credit system in Jiangsu Province, the Jiangsu Enterprise Credit Management Association carried out the publicity...

Recently, the "2023 Top 10 Most Valuable Listed Pharmaceutical Companies for Investment in China" (hereinafter referred to as the "Most Investable List") was announced, with JumpCan Pharmaceutical securing a place on the list due to its strong development quality.